{"id":"tp-47199","type":"article-newspaper","title":"Vertex Pharmaceuticals Raises 2026 Revenue Guidance After Mixed Q3","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/47199","datePublished":"2026-11-03T02:59:10.000Z","dateModified":"2026-11-03T02:59:10.000Z","language":"en","abstract":"The new range tops out below the $13.28 billion consensus estimate, as quarterly revenue beat estimates and the bottom-line result missed.","section":"Business","references":[]}